Phase I Clinical Study of Haploid Hematopoietie Stem CellTransplantation Combined With Hypoxic 3D-Cultured Umbilical Cord Mesenchymal Stem Cells for the Treatment of Severe Aplastic Anemia

• Status: ENROLLING_BY_INVITATION
• Trial end date: 2026-12-31

Summary

Efficacy and Safety of Sequential Infusion of Hypoxic 3D-Cultured Umbilical Cord Mesenchymal Stem Cells in Haploidentical Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia: A Multicenter, Randomized, Phase 1 Trial

• Phase: PHASE1

Details

• Lead Sponsor: Chinese PLA General Hospital
• Collaborators: Beijing 302 Hospital; Beijing Dajikanghua Biotechnology Co., Ltd.; Beijing Friendship Hospital; General Hospital of Shenzhen University; Pollon Life Co., Ltd.; The First Medical Center of Chinese PLA General Hospital; The Fourth Medical Center of Chinese PLA General Hospital; The University of Hong Kong-Shenzhen Hospital; Yan'an University Affiliated Hospital